1482 related articles for article (PubMed ID: 9459643)
1. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
Decousus H; Leizorovicz A; Parent F; Page Y; Tardy B; Girard P; Laporte S; Faivre R; Charbonnier B; Barral FG; Huet Y; Simonneau G
N Engl J Med; 1998 Feb; 338(7):409-15. PubMed ID: 9459643
[TBL] [Abstract][Full Text] [Related]
2. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.
PREPIC Study Group
Circulation; 2005 Jul; 112(3):416-22. PubMed ID: 16009794
[TBL] [Abstract][Full Text] [Related]
3. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
Levine M; Gent M; Hirsh J; Leclerc J; Anderson D; Weitz J; Ginsberg J; Turpie AG; Demers C; Kovacs M
N Engl J Med; 1996 Mar; 334(11):677-81. PubMed ID: 8594425
[TBL] [Abstract][Full Text] [Related]
4. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
5. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
Koopman MM; Prandoni P; Piovella F; Ockelford PA; Brandjes DP; van der Meer J; Gallus AS; Simonneau G; Chesterman CH; Prins MH
N Engl J Med; 1996 Mar; 334(11):682-7. PubMed ID: 8594426
[TBL] [Abstract][Full Text] [Related]
6. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.
Agnelli G; Piovella F; Buoncristiani P; Severi P; Pini M; D'Angelo A; Beltrametti C; Damiani M; Andrioli GC; Pugliese R; Iorio A; Brambilla G
N Engl J Med; 1998 Jul; 339(2):80-5. PubMed ID: 9654538
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; van den Berg-Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
N Engl J Med; 2003 Oct; 349(18):1695-702. PubMed ID: 14585937
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M;
N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587
[TBL] [Abstract][Full Text] [Related]
9. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
10. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.
Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E
N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144
[TBL] [Abstract][Full Text] [Related]
11. [Experiences with temporary vena cava filters in 114 at-risk patients with thrombosis or thromboembolism].
Scholz KH; Just M; Buchwald AB; Werner GS; Stille-Siegener M; Kreuzer H
Dtsch Med Wochenschr; 1999 Mar; 124(11):307-13. PubMed ID: 10209531
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
[TBL] [Abstract][Full Text] [Related]
13. [Vena cava umbrella filter: complications and treatment].
Ritter R; Pillny M; Grabitz K; Sandmann W
Dtsch Med Wochenschr; 1998 Sep; 123(37):1059-64. PubMed ID: 9762049
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
[TBL] [Abstract][Full Text] [Related]
15. [Prevention and treatment of deep venous thrombosis: prevention of pulmonary embolism].
Coccheri S; Palareti G
Cardiologia; 1994 Dec; 39(12 Suppl 1):341-5. PubMed ID: 7634294
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism.
ten Cate JW; Koopman MM; Prins MH; Büller HR
Thromb Haemost; 1995 Jul; 74(1):197-203. PubMed ID: 8578457
[TBL] [Abstract][Full Text] [Related]
17. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
18. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N
N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777
[TBL] [Abstract][Full Text] [Related]
19. Electronic alerts to prevent venous thromboembolism among hospitalized patients.
Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ
N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007
[TBL] [Abstract][Full Text] [Related]
20. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis.
Brandjes DP; Heijboer H; Büller HR; de Rijk M; Jagt H; ten Cate JW
N Engl J Med; 1992 Nov; 327(21):1485-9. PubMed ID: 1406880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
